Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1

被引:316
作者
Ma, LJ
Mao, SL
Taylor, KL
Kanjanabuch, T
Guan, YF
Zhang, YH
Brown, NJ
Swift, LL
McGuinness, OP
Wasserman, DH
Vaughan, DE
Fogo, AB
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
关键词
D O I
10.2337/diabetes.53.2.336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased plasminogen activator inhibitor 1 (PAI-1) has been linked to not only thrombosis and fibrosis but also to obesity and insulin resistance. Increased PAI-1 levels have been presumed to be consequent to obesity. We investigated the interrelationships of PAI-1, obesity, and insulin resistance in a high-fat/high-carbohydrate (HF) diet-induced obesity model in wild-type (WT) and PAI-1-deficient mice (PAI-1(-/-)). Obesity and insulin resistance developing in WT mice on an HF diet were completely prevented in mice lacking PAI-1. PAI-1(-/-) mice on an HF diet had increased resting metabolic rates and total energy expenditure compared with WT mice, along with a marked increase in uncoupling protein 3 mRNA expression in skeletal muscle, likely mechanisms contributing to the prevention of obesity. In addition, insulin sensitivity was enhanced significantly in PAI-1(-/-) mice on an HF diet, as shown by euglycemic-hyperinsulinemic clamp studies. Peroxisome proliferator-activated receptor (PPAR)-gamma and adiponectin mRNA, key control molecules in lipid metabolism and insulin sensitivity, were maintained in response to an HF diet in white adipose tissue in PAI-1(-/-) mice, contrasting with downregulation in WT mice. This maintenance of PPAR-gamma and adiponectin may also contribute to the observed maintenance of body weight and insulin sensitivity in PAI-1(-/-) mice. Treatment in WT mice on an HF diet with the angiotensin type 1 receptor antagonist to downregulate PAI-1 indeed inhibited PAI-1 increases and ameliorated diet-induced obesity, hyperglycemia, and hyperinsulinemia. PAI-1 deficiency also enhanced basal and insulin-stimulated glucose uptake in adipose cells in vitro. Our data suggest that PAI-1 may not merely increase in response to obesity and insulin resistance, but may have a direct causal role in obesity and insulin resistance. Inhibition of PAI-1 might provide a novel anti-obesity and anti-insulin resistance treatment.
引用
收藏
页码:336 / 346
页数:11
相关论文
共 83 条
  • [1] Adipose tissue as an endocrine organ
    Ahima, RS
    Flier, JS
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) : 327 - 332
  • [2] Angiotensinogen, angiotensin II and adipose tissue development
    Ailhaud, G
    Fukamizu, A
    Massiera, F
    Negrel, R
    Saint-Marc, P
    Teboul, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (Suppl 4) : S33 - S35
  • [3] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [4] Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: Association with increased plasminogen activator inhibitor-1
    Aso, Y
    Matsumoto, S
    Fujiwara, Y
    Tayama, K
    Inukai, T
    Takemura, Y
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (04): : 471 - 476
  • [5] PPARγ, the ultimate thrifty gene
    Auwerx, J
    [J]. DIABETOLOGIA, 1999, 42 (09) : 1033 - 1049
  • [6] Obesity-associated activation of angiotensin and endothelin in the cardiovascular system
    Barton, M
    Carmona, R
    Ortmann, J
    Krieger, JE
    Traupe, T
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (06) : 826 - 837
  • [7] Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity
    Bastard, JP
    Piéroni, L
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (10) : 455 - 461
  • [8] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [9] BJORNTORP P, 1978, J LIPID RES, V19, P316
  • [10] Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean
    Clapham, JC
    Arch, JRS
    Chapman, H
    Haynes, A
    Lister, C
    Moore, GBT
    Piercy, V
    Carter, SA
    Lehner, I
    Smith, SA
    Beeley, LJ
    Godden, RJ
    Herrity, N
    Skehel, M
    Changani, KK
    Hockings, PD
    Reid, DG
    Squires, SM
    Hatcher, J
    Trail, B
    Latcham, J
    Rastan, S
    Harper, AJ
    Cadenas, S
    Buckingham, JA
    Brand, MD
    Abuin, A
    [J]. NATURE, 2000, 406 (6794) : 415 - 418